CUD-005

N/A

Report date: 2024/03/15 20:05:13

Base Information

Drug NameCUD-005
Drug Alias Name个体化抗肝纤维化巨噬细胞注射液CUD005CUD-005
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSichuan Kangdesai Medical Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSichuan Kangdesai Medical Technology Co LtdAnhui Provincial Hospital
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A